Lannett Company, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Philadelphia PA United States (1942)
Status: No NME R&D (1942)

Organization Overview

First Clinical Trial
2014
NCT01746940
First Marketed Drug
1955
reserpine (serpasil)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LANNETT | LANNETT CO INC | Lannett Company, Inc. | LANNETT HOLDINGS INC | PAL PAK | PHARMERAL